Fingerprint
Dive into the research topics where Claudia Rössig is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Accelerating Drug Development for Neuroblastoma: Consensus Statement From the Third Neuroblastoma Drug Development Strategy Forum
DuBois, S. G., Moreno, L., Anderson, J., Asgharzadeh, S., Bagatell, R., Beck-Popovic, M., Belle, J., Berlanga, P., Bird, N. J., Chesler, L., Durbin, A., Eggert, A., Eilers, M., Federico, S. M., Fischer, M., Gatz, S. A., George, R. E., George, S., Goldsmith, K. C. & Gray, J. & 25 others, , Sept 2025, In: Pediatric Blood and Cancer. 72, 9, e31831.Research output: Contribution to journal › Review article › peer-review
Open Access6 Citations (Scopus) -
B7-H3 in the tumor microenvironment: Implications for CAR T cell therapy in pediatric solid tumors
Jansen, L., Wienke, J., Molkenbur, R., Rossig, C. & Meissner, R., 11 Oct 2025, In: Cancer and Metastasis Reviews. 44, 4, 77.Research output: Contribution to journal › Review article › peer-review
Open Access6 Citations (Scopus) -
Multiomic analysis uncovers a continuous spectrum of differentiation and Wnt-MDK-driven immune evasion in hepatoblastoma
Münter, D., de Faria, F. W., Richter, M., Aranda-Pardos, I., Hotfilder, M., Walter, C., Paga, E., Inserte, C., Albert, T. K., Roy, R., Rahman, S., Riedel, N. C., Müller, V., Pascher, A., Wiebe, K., Schmid, I., Vokuhl, C., Winkler, B., Jüttner, E. & Vieth, S. & 11 others, , Aug 2025, In: Journal of Hepatology. 83, 2, p. 367-382 16 p.Research output: Contribution to journal › Article › peer-review
Open Access12 Citations (Scopus) -
Chimeric Antigen Receptor (CAR) T-Cell Products for Pediatric Cancers: Why Alternative Development Paths Are Needed
International BFM Study Group (I-BFM) & Innovative Therapies for Children with Cancer (ITCC), and the European Society for Paediatric Oncology (SIOPE), 20 Jan 2024, In: Journal of Clinical Oncology. 42, 3, p. 253-257 5 p.Research output: Contribution to journal › Comment/debate
17 Citations (Scopus) -
Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050): a multicentre, open-label, multicohort, phase 1/2 study
Gaspar, N., Venkatramani, R., Hecker-Nolting, S., Melcon, S. G., Locatelli, F., Bautista, F., Longhi, A., Lervat, C., Entz-Werle, N., Casanova, M., Aerts, I., Strauss, S. J., Thebaud, E., Morland, B., Nieto, A. C., Marec-Berard, P., Gambart, M., Rossig, C., Okpara, C. E. & He, C. & 2 others, , Sept 2021, In: The Lancet Oncology. 22, 9, p. 1312-1321 10 p.Research output: Contribution to journal › Article › peer-review
85 Citations (Scopus)